WuXi AppTec Receives 2009 Schering-Plough Excellence Award
Oct 30, 2009
October 30, 2009 – Shanghai, China – WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company, with operations in China and the United States, today announced that it had received the 2009 Excellence Award from Schering-Plough.
The award recognizes WuXi's contributions to Schering-Plough's success in a range of research projects, from the creation of compound libraries to medicinal chemistry. The partnership has grown in size and scope from a handful of employees four years ago to a large, multidisciplinary team today. WuXi has consistently exceeded Schering-Plough's expectations and earned high customer satisfaction ratings. By developing a comprehensive internal training system, implementing efficient project management, and kindling a collaborative team spirit, the WuXi team has overcome numerous hurdles.
"We are pleased and honored to receive this award from Schering-Plough in recognition of the efforts of our talented and dedicated team of scientists," commented Dr. Ge Li, Chairman and CEO of WuXi AppTec. "Commitment to excellent customer service drives everything we do."
About WuXi AppTec and WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, we provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners to improve the success of research and shorten the time of development cost effectively in discovering and developing drugs and medical devices. Please visit: http://www.wuxiapptec.com.